Home »
Academic Articles »
C »
Evaluating the diagnostic value and prospects of genomic and mutational sequencing in malignant transformation of oral leukoplakia
Evaluating the diagnostic value and prospects of genomic and mutational sequencing in malignant transformation of oral leukoplakia
Jian Yuan
(Department of Stomatology, Affiliated Hospital of Xuzhou Medical University, School of Stomatology, Xuzhou Medical University, Xuzhou, Jiangsu Province, China)
Yuhan Zhu
(Department of Oral and Maxillofacial-Head and Neck Oncology, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China; College of Stomatology, Shanghai Jiao Tong University, National Center for Stomatology, National Clinical Research Center for Oral Diseases, Shanghai Key Laboratory of Stomatology, Shanghai Research Institute of Stomatology, Shanghai, China)
Zirui Wang
(College of Stomatology, Shanghai Jiao Tong University, National Center for Stomatology, National Clinical Research Center for Oral Diseases, Shanghai Key Laboratory of Stomatology, Shanghai Research Institute of Stomatology, Shanghai, China)
Zhongjing Lv
(Department of Stomatology, Affiliated Hospital of Xuzhou Medical University, School of Stomatology, Xuzhou Medical University, Xuzhou, Jiangsu Province, China; Jiangsu Center for the Collaboration and Innovation of Cancer Biotherapy, Xuzhou Medical University, Xuzhou, Jiangsu Province, China; Corresponding author. Department of Stomatology, Affiliated Hospital of Xuzhou Medical University, 99 Huaihai Road, Xuzhou, Jiangsu Province 221000, China.)
Wei Liu
(Department of Oral and Maxillofacial-Head and Neck Oncology, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China; College of Stomatology, Shanghai Jiao Tong University, National Center for Stomatology, National Clinical Research Center for Oral Diseases, Shanghai Key Laboratory of Stomatology, Shanghai Research Institute of Stomatology, Shanghai, China; Corresponding author. Department of Oral and Maxillofacial-Head and Neck Oncology, Shanghai Ninth People's Hospital, 500 Quxi Road, Shanghai 200011, China.)
Genomic and mutational sequencing in malignant transformation of oral leukoplakia (OLK) has emergingly gained momentum. In this short communication, we identified 5 retrospective follow-up studies and 5 cross-section comparative studies on this issue using formalin-fixed paraffin-embedded tissues. Copy number alteration (CNA) was demonstrated to increase with the grade of oral dysplasia. CNA-based algorithms showed better prediction performances than histological grade in assessing the risk of OLK malignant transformation. Importantly, we conducted a pooled-analysis on the mutation frequencies of the common oral cancer driver genes extracted from individual studies. The most common mutation gene was found to be TP53 (26.26 %; 95 % confidence intervals (CI), 20.61–32.82 %), followed by NOTCH1 (23.23 %; 95%CI, 17.87–29.61 %), FAT1 (16.67 %; 95%CI, 12.08–22.52 %), and CDKN2A (10.61 %; 95%CI, 6.98–15.73 %). Collectively, it is promising to establish molecular subtyping and risk stratification of OLK patients using genomic and mutational sequencing. We recommend the well-designed studies with a larger OLK patient population with clinical endpoints using fresh or frozen tissues and matched optimal samples as controls in further investigations.
Jian Yuan, Yuhan Zhu, Zirui Wang, et al. (2025). "Evaluating the diagnostic value and prospects of genomic and mutational sequencing in malignant transformation of oral leukoplakia". Journal of Dental Sciences. https://doi.org/10.1016/j.jds.2025.07.016